Icon ICLR
NASDAQ ICLR
$169.68 -4.26 (-2.45%)
At close: Sep 17, 2026 · 4:00 PM EDT

Icon (ICLR) Total Current Liabilities (2009 - 2026)

Icon's (ICLR) quarterly Total Current Liabilities came in at $3.9 billion in Q2 2026, up 53.88% year-over-year from $2.6 billion in Q2 2025, and up 24.14% quarter-over-quarter from $3.2 billion in Q1 2026.

Analysis

Icon (ICLR) Total Current Liabilities (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Total Current Liabilities for 18 consecutive years, with $3.9 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Total Current Liabilities rose 53.88% year-over-year to $3.9 billion in Q2 2026; TTM through Jun 2026 was $3.9 billion, a 53.88% increase from a year earlier, with the FY2025 full-year figure at $3.2 billion, up 15.68% from the prior year.
  • Total Current Liabilities was $3.9 billion for Q2 2026 at Icon, up from $3.2 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $3.9 billion in Q2 2026 and troughed at $2.5 billion in Q2 2022.
  • A 5-year average of $2.9 billion and a median of $2.8 billion in 2023 frame the typical range for Total Current Liabilities.
  • The widest YoY moves for Total Current Liabilities: up 124.59% in 2022, down 70.74% in 2022.
  • Over 5 years, Total Current Liabilities stood at $2.9 billion in 2022, then declined by 6.81% to $2.7 billion in 2023, then increased by 1.2% to $2.8 billion in 2024, then climbed by 15.68% to $3.2 billion in 2025, then grew by 23.11% to $3.9 billion in 2026.
  • The last three Total Current Liabilities figures came in at $3.9 billion (Q2 2026), $3.2 billion (Q1 2026), and $3.2 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 8.82 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 1.44 Bn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 3.93 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 1.13 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 963.70 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - 363.19 Mn
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 72.74 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 18.73 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 4.76 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 1.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.93 Bn
Mar 31, 2026 3.17 Bn
Dec 31, 2025 3.20 Bn
Sep 30, 2025 3.22 Bn
Jun 30, 2025 2.56 Bn
Mar 31, 2025 2.69 Bn
Dec 31, 2024 2.76 Bn
Sep 30, 2024 2.82 Bn
Jun 30, 2024 2.74 Bn
Mar 31, 2024 2.64 Bn
Dec 31, 2023 2.73 Bn
Sep 30, 2023 2.87 Bn
Jun 30, 2023 2.76 Bn
Mar 31, 2023 2.90 Bn
Dec 31, 2022 2.93 Bn
Sep 30, 2022 2.73 Bn
Jun 30, 2022 2.48 Bn
Mar 31, 2022 2.54 Bn
Dec 31, 2021 2.64 Bn
Sep 30, 2021 2.30 Bn